skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:035552/0202   Pages: 5
Recorded: 04/30/2015
Attorney Dkt #:13751-0001005
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 52
1
Patent #:
5736137
Issue Dt:
04/07/1998
Application #:
08149099
Filing Dt:
11/03/1993
Title:
THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOLABELED ANTIBODIES TO HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR TREATMENT OF B CELL LYMPHOMA
2
Patent #:
6682734
Issue Dt:
01/27/2004
Application #:
08475813
Filing Dt:
06/07/1995
Title:
THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOLABELED ANTIBODIES TO HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR TREATMENT OF B CELL LYMPHOMA
3
Patent #:
6399061
Issue Dt:
06/04/2002
Application #:
08475815
Filing Dt:
06/07/1995
Title:
CHIMERIC AND RADIOLABELED ANTIBODIES SPECIFIC TO HUMAN CD20 ANTIGEN AND USE THEREOF FOR TREATMENT OF B-CELL LYMPHOMA
4
Patent #:
5756096
Issue Dt:
05/26/1998
Application #:
08476237
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
5
Patent #:
5776456
Issue Dt:
07/07/1998
Application #:
08476275
Filing Dt:
06/07/1995
Title:
THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOLABELED ANTIBODIES TO HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR TREATMENT OF B CELL LYMPHOMA
6
Patent #:
5750105
Issue Dt:
05/12/1998
Application #:
08476349
Filing Dt:
06/07/1995
Title:
RECOMBINANT ANTIBODIES FOR HUMAN THERAPY
7
Patent #:
5843439
Issue Dt:
12/01/1998
Application #:
08478967
Filing Dt:
06/07/1995
Title:
THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOLABELED ANTIBODIES TO HUMAN B LYMPHOCYTE RESTRICTED DIFFERENTIATION ANTIGEN FOR TREATMENT OF B CELL LYMPHOMA
8
Patent #:
6113898
Issue Dt:
09/05/2000
Application #:
08487550
Filing Dt:
06/07/1995
Title:
HUMAN B7.1-SPECIFIC PRIMATIZED ANTIBODIES AND TRANSFECTOMAS EXPRESSING SAID ANTIBODIES
9
Patent #:
6136310
Issue Dt:
10/24/2000
Application #:
08523894
Filing Dt:
09/06/1995
Title:
RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY
10
Patent #:
6017733
Issue Dt:
01/25/2000
Application #:
09013092
Filing Dt:
01/26/1998
Title:
IMPAIRED DOMINANT SELECTABLE MARKER SEQUENCE AND INTRONIC INSERTION STRATEGIES FOR ENHANCEMENT OF EXPRESSION OF GENE PRODUCT AND EXPRESSION VECTOR SYSTEMS COMPRISING SAME
11
Patent #:
6444793
Issue Dt:
09/03/2002
Application #:
09325256
Filing Dt:
06/03/1999
Title:
HYDROPHOBICALLY-MODIFIED PROTEIN COMPOSITIONS AND METHODS
12
Patent #:
6709654
Issue Dt:
03/23/2004
Application #:
09383916
Filing Dt:
08/26/1999
Title:
TREATMENT OF PSORIASIS USING ANTI-B7.1(CD80) ANTIBODIES
13
Patent #:
7682612
Issue Dt:
03/23/2010
Application #:
09436347
Filing Dt:
11/09/1999
Title:
TREATMENT OF HEMATOLOGIC MALIGNANCIES ASSOCIATED WITH CIRCULATING TUMOR CELLS USING CHIMERIC ANTI-CD20 ANTIBODY
14
Patent #:
7820161
Issue Dt:
10/26/2010
Application #:
09564288
Filing Dt:
05/04/2000
Title:
TREATMENT OF AUTOIMMUNE DISEASES
15
Patent #:
7175847
Issue Dt:
02/13/2007
Application #:
09576424
Filing Dt:
05/22/2000
Title:
TREATING INTESTINAL INFLAMMATION WITH ANTI-CD80 ANTIBODIES THAT DO NOT INHBIT CD80 BINDING TO CTLA-4
16
Patent #:
6451284
Issue Dt:
09/17/2002
Application #:
09625856
Filing Dt:
07/26/2000
Title:
NEW CLINICAL PARAMETERS FOR DETERMINING HEMATOLOGIC TOXICITY PRIOR TO RADIOIMMUNOTHERAPHY
17
Patent #:
8557244
Issue Dt:
10/15/2013
Application #:
09628187
Filing Dt:
07/28/2000
Title:
TREATMENT OF AGGRESSIVE NON-HODGKINS LYMPHOMA WITH ANTI-CD20 ANTIBODY
18
Patent #:
6893638
Issue Dt:
05/17/2005
Application #:
09758173
Filing Dt:
01/12/2001
Publication #:
US20010024648
Pub Dt:
09/27/2001
Title:
METHODS FOR TREATING B CELL LYMPHOMA USING CD80-SPECIFIC ANTIBODIES
19
Patent #:
6896885
Issue Dt:
05/24/2005
Application #:
09822672
Filing Dt:
04/02/2001
Publication #:
US20020012665
Pub Dt:
01/31/2002
Title:
COMBINED USE OF ANTI-CYTOKINE ANTIBODIES OR ANTAGONISTS AND ANTI-CD20 FOR TREATMENT OF B CELL LYMPHOMA
20
Patent #:
6998125
Issue Dt:
02/14/2006
Application #:
09853581
Filing Dt:
05/14/2001
Publication #:
US20010019715
Pub Dt:
09/06/2001
Title:
SYNERGISTIC COMPOSITION AND METHODS FOR TREATING NEOPLASTIC OR CANCEROUS GROWTHS AND FOR RESTORING OR BOOSTING HEMATOPOIESIS
21
Patent #:
6846476
Issue Dt:
01/25/2005
Application #:
09883962
Filing Dt:
06/20/2001
Publication #:
US20020039557
Pub Dt:
04/04/2002
Title:
TREATMENT OF B-CELL ASSOCIATED DISEASES SUCH AS MALIGNANCES AND AUTOIMMUNE DISEASES USING A COLD ANTI-CD20 ANTIBODY/RADIOLABELED ANTI-CD22 ANTIBODY COMBINATION
22
Patent #:
7381560
Issue Dt:
06/03/2008
Application #:
09911692
Filing Dt:
07/25/2001
Publication #:
US20030095963
Pub Dt:
05/22/2003
Title:
EXPRESSION AND USE OF ANTI-CD20 ANTIBODIES
23
Patent #:
7422739
Issue Dt:
09/09/2008
Application #:
09911703
Filing Dt:
07/25/2001
Publication #:
US20080089893
Pub Dt:
04/17/2008
Title:
ANTI-CD20 ANTIBODIES
24
Patent #:
7319139
Issue Dt:
01/15/2008
Application #:
10058069
Filing Dt:
01/29/2002
Publication #:
US20070280881
Pub Dt:
12/06/2007
Title:
TAG-72 SPECIFIC CH2 DOMAIN DELETED ANTIBODIES
25
Patent #:
7153508
Issue Dt:
12/26/2006
Application #:
10073138
Filing Dt:
02/13/2002
Publication #:
US20020187146
Pub Dt:
12/12/2002
Title:
TREATMENT OF B CELL LYMPHOMA USING ANTI-CD80 ANTIBODIES THAT DO NOT INHIBIT THE BINDING OF CD80 TO CTLA-4
26
Patent #:
7195750
Issue Dt:
03/27/2007
Application #:
10195426
Filing Dt:
07/16/2002
Publication #:
US20030211038
Pub Dt:
11/13/2003
Title:
NEW CLINICAL PARAMETERS FOR DETERIMING HEMATOLOGIC TOXICITY PRIOR TO RADIOIMMUNOTHERAPY
27
Patent #:
7744877
Issue Dt:
06/29/2010
Application #:
10238681
Filing Dt:
09/11/2002
Publication #:
US20030147885
Pub Dt:
08/07/2003
Title:
EXPRESSION AND USE OF ANTI-CD20 ANTIBODIES
28
Patent #:
7220356
Issue Dt:
05/22/2007
Application #:
10661086
Filing Dt:
09/12/2003
Publication #:
US20040241878
Pub Dt:
12/02/2004
Title:
METHOD OF PURIFYING POLYPEPTIDES BY SIMULATED MOVING BED CHROMATOGRAPHY
29
Patent #:
7157276
Issue Dt:
01/02/2007
Application #:
10871261
Filing Dt:
06/21/2004
Publication #:
US20050037333
Pub Dt:
02/17/2005
Title:
USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURES
30
Patent #:
7323170
Issue Dt:
01/29/2008
Application #:
10986780
Filing Dt:
11/15/2004
Publication #:
US20050129688
Pub Dt:
06/16/2005
Title:
ANTI-CD80 ANTIBODIES
31
Patent #:
7192585
Issue Dt:
03/20/2007
Application #:
11139499
Filing Dt:
05/31/2005
Publication #:
US20050260205
Pub Dt:
11/24/2005
Title:
CD80 SPECIFIC ANTIBODIES
32
Patent #:
7414123
Issue Dt:
08/19/2008
Application #:
11464123
Filing Dt:
08/11/2006
Publication #:
US20080038254
Pub Dt:
02/14/2008
Title:
NUCLEIC ACIDS ENCODING 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
33
Patent #:
7425447
Issue Dt:
09/16/2008
Application #:
11464133
Filing Dt:
08/11/2006
Publication #:
US20060275291
Pub Dt:
12/07/2006
Title:
HOST CELLS EXPRESSING 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
34
Patent #:
7417128
Issue Dt:
08/26/2008
Application #:
11553302
Filing Dt:
10/26/2006
Publication #:
US20070128185
Pub Dt:
06/07/2007
Title:
7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
35
Patent #:
7759117
Issue Dt:
07/20/2010
Application #:
11616772
Filing Dt:
12/27/2006
Publication #:
US20070267360
Pub Dt:
11/22/2007
Title:
USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURES
36
Patent #:
NONE
Issue Dt:
Application #:
11665525
Filing Dt:
06/04/2009
Publication #:
US20090238762
Pub Dt:
09/24/2009
Title:
Method for treating joint damage
37
Patent #:
8608960
Issue Dt:
12/17/2013
Application #:
11751147
Filing Dt:
05/21/2007
Publication #:
US20070215534
Pub Dt:
09/20/2007
Title:
METHOD OF PURIFYING POLYPEPTIDES BY SIMULATED MOVING BED CHROMATOGRAPHY
38
Patent #:
7501264
Issue Dt:
03/10/2009
Application #:
11840591
Filing Dt:
08/17/2007
Publication #:
US20080095769
Pub Dt:
04/24/2008
Title:
METHODS OF PRODUCING 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
39
Patent #:
7510712
Issue Dt:
03/31/2009
Application #:
11840593
Filing Dt:
08/17/2007
Publication #:
US20090010939
Pub Dt:
01/08/2009
Title:
METHODS OF TREATING RHEUMATOID ARTHRITIS WITH 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
40
Patent #:
7491393
Issue Dt:
02/17/2009
Application #:
11840594
Filing Dt:
08/17/2007
Publication #:
US20080114156
Pub Dt:
05/15/2008
Title:
METHODS OF INHIBITING IL-2 PRODUCTION BY T CELLS BY ADMINISTERING 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
41
Patent #:
7510713
Issue Dt:
03/31/2009
Application #:
11840597
Filing Dt:
08/17/2007
Publication #:
US20090012271
Pub Dt:
01/08/2009
Title:
METHODS OF INDUCING IMMUNOSUPPRESSION BY ADMINISTERING 7C10 AND 16C10 CD80-SPECIFIC ANTIBODIES
42
Patent #:
8329172
Issue Dt:
12/23/2013
Application #:
11840956
Filing Dt:
08/23/2013
Publication #:
US20080038261
Pub Dt:
02/14/2008
Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
43
Patent #:
NONE
Issue Dt:
Application #:
12100303
Filing Dt:
04/09/2008
Publication #:
US20090074760
Pub Dt:
03/19/2009
Title:
USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
44
Patent #:
8206711
Issue Dt:
06/26/2012
Application #:
12629472
Filing Dt:
12/02/2009
Publication #:
US20100080769
Pub Dt:
04/01/2010
Title:
TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA USING ANTI-CD20 ANTIBODIES
45
Patent #:
8545843
Issue Dt:
10/01/2013
Application #:
12886171
Filing Dt:
09/20/2010
Publication #:
US20110008337
Pub Dt:
01/13/2011
Title:
TREATMENT OF VASCULITIS
46
Patent #:
NONE
Issue Dt:
Application #:
13051054
Filing Dt:
03/18/2011
Publication #:
US20110165159
Pub Dt:
07/07/2011
Title:
USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT
47
Patent #:
9198955
Issue Dt:
12/01/2015
Application #:
13421197
Filing Dt:
03/15/2012
Publication #:
US20120237479
Pub Dt:
09/20/2012
Title:
METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN
48
Patent #:
NONE
Issue Dt:
Application #:
13524837
Filing Dt:
06/15/2012
Publication #:
US20120251535
Pub Dt:
10/04/2012
Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
49
Patent #:
9296821
Issue Dt:
03/29/2016
Application #:
13524896
Filing Dt:
06/15/2012
Publication #:
US20120258102
Pub Dt:
10/11/2012
Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES
50
Patent #:
NONE
Issue Dt:
Application #:
13868753
Filing Dt:
04/23/2013
Publication #:
US20130273039
Pub Dt:
10/17/2013
Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
51
Patent #:
NONE
Issue Dt:
Application #:
13885446
Filing Dt:
08/30/2013
Publication #:
US20130331554
Pub Dt:
12/12/2013
Title:
ENRICHMENT AND CONCENTRATION OF SELECT PRODUCT ISOFORMS BY OVERLOADED BIND AND ELUTE CHROMATOGRAPHY
52
Patent #:
8821873
Issue Dt:
09/02/2014
Application #:
14045375
Filing Dt:
10/03/2013
Publication #:
US20140030263
Pub Dt:
01/30/2014
Title:
TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY
Assignor
1
BIOGEN IDEC INC.
Exec Dt:
03/23/2015
Assignee
1
BIOGEN INC.
250 BINNEY STREET
CAMBRIDGE, MASSACHUSETTS 02142
Correspondence name and address
JACK BRENNAN
FISH & RICHARDSON P.C.
P.O.BOX 1022
MINNEAPOLIS, MN 55440-1022

Search Results as of: 06/03/2024 09:45 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT